Please enter the email address you used to register, then we will send you a link to choose a new password
ORCL: 9% | Oracle shares are trading higher following better-than-expected Q1 financial results. JMP Securities upgraded the stock from Market Perform to Market Outperform following the report.
VRDN: 16% | Viridian Therapeutics shares are trading higher after the company reported topline data from the THRIVE phase 3 clinical trial of VRDN-001 in patients with active thyroid eye disease.
CNTA: 18% | Centessa Pharmaceuticals Announced Interim Data From An Ongoing Phase 1 Trial Of ORX750, In Acutely Sleep-deprived Healthy Volunteers, Showing Clinically Meaningful And Statistically Significant Improvements In Mean Sleep Latency At The First Two Doses Evaluated Vs. Placebo
Posted In: CNTA ORCL VRDN